Drug data last refreshed 9h ago · AI intelligence enriched 3d ago
Morphine Sulfate is an opioid analgesic available as an oral tablet formulation used for pain management. It is a small-molecule opioid agonist that binds to mu-opioid receptors in the central nervous system to provide analgesia. This product is a mature, established therapy for moderate to severe pain across multiple patient populations.
As a mature opioid in the LOE-approaching stage, the morphine sulfate brand team likely faces pressuring generic competition and declining exclusivity, signaling potential consolidation or rationalization of the commercial organization.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo
Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)
Working on morphine sulfate offers limited growth potential given its LOE status and mature lifecycle stage. Career value lies primarily in managed care strategy, generic transition planning, and cost-containment execution rather than innovation or market expansion.
Worked on MORPHINE SULFATE at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo